Karl T Weber and Yao Sun

Recruitable ACE and tissue repair in the infarcted heart
J Renin Angiotensin Aldosterone Syst 2000 1: 295-303. [PDF] [References]  

Giuseppe A Sagnella

Practical implications of current natriuretic peptide research
J Renin Angiotensin Aldosterone Syst 2000 1: 304-315. [PDF] [References]  

Neal Padmanabhan, Sandosh Padmanabhan, and John MC Connell

Genetic basis of cardiovascular disease — the renin-angiotensin-aldosterone system as a paradigm
J Renin Angiotensin Aldosterone Syst 2000 1: 316-324. [PDF] [References]  

Peter S Sever

To block the renin system or the calcium channel in hypertension — where do we stand?
J Renin Angiotensin Aldosterone Syst 2000 1: 325-327. [PDF] [References]  

Barry M Brenner, Mark E Cooper, Dick de Zeeuw, Jean-Pierre Grunfeld, William F Keane, Kiyoshi Kurokawa, Janet B McGill, William E Mitch, Hans Henrik Parving, Guiseppe Remuzzi, Arthur B Ribeiro, Mark D Schluchter, Duane Snavely, Zhongxin Zhang, Roger Simpson, Denise Ramjit, Shahnaz Shahinfar, and RENAAL Study Investigators

The losartan renal protection study — rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)
J Renin Angiotensin Aldosterone Syst 2000 1: 328-335. [Abstract] [PDF] [References]  

Gustav G Belz, Kerstin Breithaupt-Grögler, Raunhild Butzer, Winfried Fuchs, Christian Hausdorf, and Christian Mang

The pharmacological potency of various AT1 antagonists assessed by Schild regression technique in man
J Renin Angiotensin Aldosterone Syst 2000 1: 336-341. [Abstract] [PDF] [References]  

Victor V Petrov, Robert H Fagard, and Paul J Lijnen

Transforming growth factor-β1 induces angiotensin-converting enzyme synthesis in rat cardiac fibroblasts during their differentiation to myofibroblasts
J Renin Angiotensin Aldosterone Syst 2000 1: 342-352. [Abstract] [PDF] [References]  

Mats Bojestig, Fredrik H Nystrom, Hans J Arnqvist, Johnny Ludvigsson, and Bengt E Karlberg

The renin-angiotensin-aldosterone system is suppressed in adults with Type 1 diabetes
J Renin Angiotensin Aldosterone Syst 2000 1: 353-356. [Abstract] [PDF] [References]  

Katja Lottermoser, Hans-Jörg Hertfelder, Martin Wehling, Beate Schiermeyer, Hans Vetter, and Rainer Düsing

Effects of the mineralocorticoid fludrocortisone on fibrinolytic function in healthy subjects
J Renin Angiotensin Aldosterone Syst 2000 1: 357-360. [Abstract] [PDF] [References]  

Georg Nickenig, Alexander Stäblein, Sven Wassmann, Christoph Wyen, Cornelius Müller, and Michael Böhm

Acute effects of ACE inhibition on coronary endothelial dysfunction
J Renin Angiotensin Aldosterone Syst 2000 1: 361-364. [Abstract] [PDF] [References]  

Arie Erman, Geoffrey Boner, and David J van Dijk

Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
J Renin Angiotensin Aldosterone Syst 2000 1: 365-368. [Abstract] [PDF] [References]  

Marwan E El-Sabban, Khaled A Hassan, Adel E Birbari, Khalil M Bitar, and Anwar B Bikhazi

Angiotensin II binding and extracellular matrix remodelling in a rat model of myocardial infarction
J Renin Angiotensin Aldosterone Syst 2000 1: 369-378. [Abstract] [PDF] [References]  

Chiming Wei, Marcelo G Cardarelli, Stephen W Downing, and Joseph S McLaughlin

The effect of angiotensin II on mitogen-activated protein kinase in human cardiomyocytes
J Renin Angiotensin Aldosterone Syst 2000 1: 379-384. [Abstract] [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.